Consequently, traditional tests of bias, comparative effect sizes, and other statistical measures were not used
NICE Technology Appraisal (TA875) on semaglutide for weight management specifies that within the NHS, Wegovy should be prescribed by specialist weight management services and used for a maximum of 2 years
It can be prescribed for memory impairment, decreased performance, depression
There's also evidence that GLP-1 agonists, like semaglutide and tirzepatide sold as Mounjaro, Ozempic, Wegovy and Zepound lower the risk of cardiovascular diseases protect the kidney and the liver, reduce inflammation and pain, prevent addiction and substance abuse, help people with arthritis and those with sleep apnea